Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.

Manolakopoulos S, Deutsch MJ, Anagnostou O, Karatapanis S, Tiniakou E, Papatheodoridis GV, Georgiou E, Manesis E, Tzourmakliotis D, Archimandritis AJ.

Liver Int. 2010 Nov;30(10):1454-60. doi: 10.1111/j.1478-3231.2010.02341.x. Epub 2010 Sep 16.

PMID:
20846344
2.

Pylephlebitis: an overview of non-cirrhotic cases and factors related to outcome.

Kanellopoulou T, Alexopoulou A, Theodossiades G, Koskinas J, Archimandritis AJ.

Scand J Infect Dis. 2010 Dec;42(11-12):804-11. doi: 10.3109/00365548.2010.508464. Epub 2010 Aug 25. Review.

PMID:
20735334
3.

Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection.

Savvas SP, Papakostas N, Giannaris M, Malaktari S, Koskinas J, Archimandritis AJ.

South Med J. 2010 Jun;103(6):585-8. doi: 10.1097/SMJ.0b013e3181ddd952.

PMID:
20710148
4.

Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment.

Vassilopoulos D, Sialevris K, Malahtari S, Deutsch M, Manolakopoulos S, Archimandritis AJ.

J Clin Rheumatol. 2010 Mar;16(2):88-9. doi: 10.1097/RHU.0b013e3181d0bd30. No abstract available.

PMID:
20216130
5.

The burden of incidental findings in clinical practice in a tertiary care center.

Soultati A, Alexopoulou A, Dourakis SP, Dimopoulou H, Katsaounis P, Cokkinos D, Archimandritis AJ.

Eur J Intern Med. 2010 Apr;21(2):123-6. doi: 10.1016/j.ejim.2009.12.012. Epub 2010 Jan 27.

PMID:
20206884
6.

Primary hepatic actinomycosis mimicking metastatic liver tumor.

Kanellopoulou T, Alexopoulou A, Tiniakos D, Koskinas J, Archimandritis AJ.

J Clin Gastroenterol. 2010 Jul;44(6):458-9. doi: 10.1097/MCG.0b013e3181d2ef30. No abstract available.

PMID:
20195165
7.

Primary hepatic actinomycosis.

Kanellopoulou T, Alexopoulou A, Tanouli MI, Tiniakos D, Giannopoulos D, Koskinas J, Archimandritis AJ.

Am J Med Sci. 2010 Apr;339(4):362-5. doi: 10.1097/MAJ.0b013e3181cbf47c. Review.

PMID:
20195148
8.

Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.

Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, Mamalaki A, Archimandritis AJ.

J Viral Hepat. 2010 Nov;17(11):800-6. doi: 10.1111/j.1365-2893.2009.01244.x.

PMID:
20002304
9.

Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Manolakopoulos S, Manesis EK, Archimandritis AJ.

J Clin Gastroenterol. 2010 Apr;44(4):e87-95. doi: 10.1097/MCG.0b013e3181c0945a.

PMID:
19881359
10.

Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.

Tsochatzis EA, Papatheodoridis GV, Archimandritis AJ.

Mediators Inflamm. 2009;2009:831670. doi: 10.1155/2009/831670. Epub 2009 Jun 3. Review.

11.

The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.

Giannousis IP, Papatheodoridis GV, Deutsch MJ, Manolakopoulos SG, Manesis EK, Koskinas JS, Archimandritis AJ.

Eur J Gastroenterol Hepatol. 2010 Feb;22(2):172-9. doi: 10.1097/MEG.0b013e328331115b.

PMID:
19738477
12.

Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.

Papatheodoridis GV, Chrysanthos N, Cholongitas E, Pavlou E, Apergis G, Tiniakos DG, Andrioti E, Theodossiades G, Archimandritis AJ.

J Hepatol. 2009 Nov;51(5):931-8. doi: 10.1016/j.jhep.2009.06.023. Epub 2009 Aug 3.

PMID:
19726097
13.

Current management of hepatitis B virus infection before and after liver transplantation.

Papatheodoridis GV, Cholongitas E, Archimandritis AJ, Burroughs AK.

Liver Int. 2009 Oct;29(9):1294-305. doi: 10.1111/j.1478-3231.2009.02085.x. Epub 2009 Jul 10. Review.

PMID:
19619264
14.

Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.

Tsochatzis E, Manolakopoulos S, Papatheodoridis GV, Hadziyannis E, Triantos C, Zisimopoulos K, Goulis I, Tzourmakliotis D, Akriviadis E, Manesis EK, Archimandritis AJ.

Aliment Pharmacol Ther. 2009 Nov 1;30(9):947-54. doi: 10.1111/j.1365-2036.2009.04094.x. Epub 2009 Jul 9.

15.

Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.

Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ.

Scand J Gastroenterol. 2009;44(6):752-9. doi: 10.1080/00365520902803515.

PMID:
19296398
16.

Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.

Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ.

J Viral Hepat. 2009 Jun;16(6):430-6. doi: 10.1111/j.1365-2893.2009.01077.x. Epub 2009 Feb 6.

PMID:
19200136
17.

Unusual combination of paraneoplastic manifestations in a patient with metastatic gastrointestinal stromal tumor (GIST).

Tsikrikas S, Manolakopoulos S, Deutsch M, Alexakis G, Sialevris K, Giannopoulos D, Vassilopoulos D, Archimandritis AJ.

Scand J Gastroenterol. 2008 Aug;43(8):1012-5.

PMID:
19086169
18.

Current treatment indications and strategies in chronic hepatitis B virus infection.

Papatheodoridis GV, Manolakopoulos S, Archimandritis AJ.

World J Gastroenterol. 2008 Dec 7;14(45):6902-10. Review.

19.

Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values.

Alexopoulou A, Baltayiannis G, Eroglu C, Nastos T, Dourakis SP, Archimandritis AJ, Karayiannis P.

J Med Virol. 2009 Jan;81(1):34-41. doi: 10.1002/jmv.21337.

PMID:
19031457
20.

Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.

Alexopoulou A, Dourakis SP, Mantzoukis D, Pitsariotis T, Kandyli A, Deutsch M, Archimandritis AJ.

Eur J Intern Med. 2008 Nov;19(7):505-10. doi: 10.1016/j.ejim.2007.06.030. Epub 2008 Mar 11.

PMID:
19013378
21.

Cholangiocarcinoma: a 7-year experience at a single center in Greece.

Alexopoulou A, Soultati A, Dourakis SP, Vasilieva L, Archimandritis AJ.

World J Gastroenterol. 2008 Oct 28;14(40):6213-7.

22.

Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?

Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis IS, Goulis J, Giannousis J, Bilalis A, Kafiri G, Tzourmakliotis D, Archimandritis AJ.

Hepatology. 2008 Nov;48(5):1451-9. doi: 10.1002/hep.22518.

PMID:
18924246
23.

Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.

Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ.

Scand J Gastroenterol. 2009;44(1):6-14. doi: 10.1080/00365520802273058. Review.

PMID:
18661429
24.

An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features.

Katsaounis P, Alexopoulou A, Dourakis SP, Smyrnidis A, Marinos L, Filiotou A, Archimandritis AJ.

Int J Hematol. 2008 Sep;88(2):202-205. doi: 10.1007/s12185-008-0137-9. Epub 2008 Jul 25.

PMID:
18654739
25.
26.

Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.

Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ.

Scand J Gastroenterol. 2008;43(9):1128-36. doi: 10.1080/00365520802085387.

PMID:
18609175
27.

Pseudohyperkalemia in serum: a new insight into an old phenomenon.

Sevastos N, Theodossiades G, Archimandritis AJ.

Clin Med Res. 2008 May;6(1):30-2. doi: 10.3121/cmr.2008.739. Review.

28.

Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.

Deutsch M, Vassilopoulos D, Sevastos N, Papadimitriou A, Vasiliou K, Archimandritis AJ.

Eur J Intern Med. 2008 Jun;19(4):289-91. doi: 10.1016/j.ejim.2007.04.025. Epub 2008 Jan 9.

PMID:
18471680
29.

Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease.

Gazouli M, Atsaves V, Mantzaris G, Economou M, Nasioulas G, Evangelou K, Archimandritis AJ, Anagnou NP.

Inflamm Bowel Dis. 2008 Oct;14(10):1323-30. doi: 10.1002/ibd.20488.

PMID:
18454481
30.
31.

Changes of liver and muscle enzymes activity in patients with rigor.

Sevastos N, Manesis EK, Savvas SP, Galiatsatos N, Papatheodoridis GV, Archimandritis AJ.

Eur J Intern Med. 2008 Mar;19(2):109-14. doi: 10.1016/j.ejim.2007.05.013. Epub 2008 Jan 10.

PMID:
18249306
32.

Acute splenic sequestration crisis (ASSC) in an adult patient with beta-thalassemia sickle cell disease: a life-threatening complication.

Tsikrikas S, Sialevris K, Tsochatzis E, Deutsch M, Vassilopoulos D, Vgontza N, Archimandritis AJ.

Ann Hematol. 2008 Jun;87(6):499-500. Epub 2007 Dec 13. No abstract available.

PMID:
18084762
33.

Dilated cardiomyopathy during the course of hemolytic uremic syndrome.

Alexopoulou A, Dourakis SP, Zovoilis C, Agapitos E, Androulakis A, Filiotou A, Archimandritis AJ.

Int J Hematol. 2007 Nov;86(4):333-6.

PMID:
18055340
34.

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

Papatheodoridis GV, Manolakopoulos S, Dusheiko G, Archimandritis AJ.

Lancet Infect Dis. 2008 Mar;8(3):167-78. Epub 2007 Nov 28. Review.

PMID:
18053766
35.

Adipokines and insulin resistance in chronic hepatitis C.

Tsochatzis E, Papatheodoridis GV, Archimandritis AJ.

Hepatology. 2007 Dec;46(6):2050-1; author reply 2051. No abstract available.

PMID:
18046709
36.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.

Gut. 2008 Apr;57(4):500-6. Epub 2007 Nov 19.

PMID:
18025069
37.

Sensorineural hearing loss complicating severe rickettsial diseases: report of two cases.

Tsiachris D, Deutsch M, Vassilopoulos D, Zafiropoulou R, Archimandritis AJ.

J Infect. 2008 Jan;56(1):74-6. Epub 2007 Nov 26.

PMID:
18023483
38.

Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.

Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):80-9. Epub 2007 Oct 5.

39.

Glucagonoma syndrome: survival 21 years with concurrent liver metastases.

Dourakis SP, Alexopoulou A, Georgousi KK, Delladetsima JK, Tolis G, Archimandritis AJ.

Am J Med Sci. 2007 Sep;334(3):225-7.

PMID:
17873541
40.

Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation.

Deutsch M, Koskinas J, Kountouras D, Archimandritis AJ.

J Hepatol. 2007 Nov;47(5):728-9. Epub 2007 Aug 21. No abstract available.

PMID:
17868949
41.

Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.

Tsochatzis E, Papatheodoridis GV, Manesis EK, Chrysanthos N, Kafiri G, Archimandritis AJ.

Dig Liver Dis. 2007 Oct;39(10):936-42. Epub 2007 Aug 27.

PMID:
17720637
42.

Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Manesis EK, Manolakopoulos S, Archimandritis AJ.

Hepatology. 2007 Aug;46(2):606-7; author reply 607. No abstract available.

PMID:
17661409
43.

Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.

Manesis EK, Schina M, Le Gal F, Agelopoulou O, Papaioannou C, Kalligeros C, Arseniou V, Manolakopoulos S, Hadziyannis ES, Gault E, Koskinas J, Papatheodoridis G, Archimandritis AJ.

Antivir Ther. 2007;12(3):381-8.

PMID:
17591028
44.
45.

First appearance of Crohn's disease following infliximab treatment for spondylarthropathy.

Tsochatzis E, Vassilopoulos D, Manesis EK, Papatheodoridis G, Bousiotou A, Hadziyannis E, Archimandritis AJ.

Scand J Gastroenterol. 2007 Jun;42(6):784-5. No abstract available.

PMID:
17506005
46.

Autoimmune blistering disease in a patient with Graves disease and vitiligo.

Soultati AS, Dourakis SP, Asvesti K, Nezi V, Alexopoulou A, Archimandritis AJ.

Am J Med Sci. 2007 May;333(5):309-12.

PMID:
17505176
47.

Liver involvement in acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors.

Koskinas J, Manesis EK, Zacharakis GH, Galiatsatos N, Sevastos N, Archimandritis AJ.

Scand J Gastroenterol. 2007 Apr;42(4):499-507.

PMID:
17454861
48.

Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.

Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Archimandritis AJ.

World J Gastroenterol. 2007 Feb 28;13(8):1292-4.

49.

Severe hepatitis C virus-related cryoglobulinaemic sensory-motor polyneuropathy treated with pegylated interferon-a2b and ribavirin: clinical, laboratory and neurophysiological study.

Koskinas J, Kilidireas C, Karandreas N, Kountouras D, Savvas S, Hadziyannis E, Archimandritis AJ.

Liver Int. 2007 Apr;27(3):414-20.

PMID:
17355465
50.

Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b.

Deutsch M, Manesis EK, Hadziyannis E, Vassilopoulos D, Archimandritis AJ.

Scand J Gastroenterol. 2007 Mar;42(3):408-9. No abstract available.

PMID:
17354123

Supplemental Content

Loading ...
Support Center